A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers
MDL 72.974A [(E) 4-fluoro-beta-fluorethylene benzene butanamine] has been shown in animal studies, both in vitro and in vivo, to be a potent, selective, enzyme-activated irreversible inhibitor of MAO-B (Zreika et al., 1989). This compound is under clinical development for the treatment of Parkinson’s disease.
In this double blind, randomized, placebo-controlled normal volunteer study the tolerability, effects on platelet MAO-B activity and associated pharmacokinetics of increasing single oral doses of MDL 72.974A (0.1–12 mg) were assessed.
MDL 72.974A was extremely well tolerated and no treatment-related changes in vital signs or the adjectival check-list (EWL-N) occurred. The compound caused significant dose-dependent inhibition of platelet MAO-B activity at all dose levels with a return to baseline values by day 14. The mean (± S.D.) elimination half-life of parent compound was 51 ± 26 min and mean (± S.D.) urinary excretion was 0.54 ± 0.26% of the administered dose. These results, long action on platelet MAO-B and short elimination half-life, demonstrate MDL 72.974A to be a potent, irreversible inhibitor of MAO-B in man.
KeywordsMonoamine Oxidase Single Oral Dose Platelet Rich Plasma Monoamine Oxidase Type Platelet Rich Plasma Sample
Unable to display preview. Download preview PDF.
- Fowler CJ, O’Carroll AM, Tipton KF (1984) Eeamination of dopamine by monoamine oxidase-A and-B in the rat and man. In: Tipton KF, Benedetti MS (eds) Monoamine oxidase and disease. Academic Press, London, pp 393–402.Google Scholar
- Glover V, Elsworth JD, Sandler M (1980) Dopamine oxidation and its inhibition by (−)-deprenyl in man. J Neural Transm [Suppl] 16:163–172.Google Scholar
- Heinonen EH, Rinne U (1989) Selegiline in the treatment of Parkinson’s diesease. Acta Neurol Scand 126:103–111.Google Scholar
- Janke W, Debus G (1978) Die Eigenschaftswörterliste. Hogrefe, Göttingen.Google Scholar
- Riederer P, Reynolds JP, Youdim MBH, Jellinger K (1982) In vitro tests of MAO inhibitors in human brain tissue: chemical structure and pharmacologic action. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase, basic and clinical frontiers. Excerpta Medica, Amsterdam, pp 345–350.Google Scholar